Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 19 June 1998:
Vol. 280. no. 5371, pp. 1866 - 1867
DOI: 10.1126/science.280.5371.1866
Prev | Table of Contents | Next

Viewpoint

Toward HIV Eradication or Remission: The Tasks Ahead

David D. Ho

Recent advances in the understanding of viral kinetics and drug therapies have led to the real possibility that HIV can be kept under tight control or that an infected person can be rendered totally free of virus. There are major hurdles in the way of these goals, and David Ho discusses some of the strategies being considered.

The author is at the Aaron Diamond AIDS Research Center, Rockefeller University, 455 First Avenue, New York, NY 10016, USA. E-mail: dho{at}adarc.org

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Primary Cell Model for Activation-Inducible Human Immunodeficiency Virus.
B. Burke, H. J. Brown, M. D. Marsden, G. Bristol, D. N. Vatakis, and J. A. Zack (2007)
J. Virol. 81, 7424-7434
   Abstract »    Full Text »    PDF »
Dynamics of Intermittent Viremia during Highly Active Antiretroviral Therapy in Patients Who Initiate Therapy during Chronic versus Acute and Early Human Immunodeficiency Virus Type 1 Infection.
M. Di Mascio, M. Markowitz, M. Louie, A. Hurley, C. Hogan, V. Simon, D. Follmann, D. D. Ho, and A. S. Perelson (2004)
J. Virol. 78, 10566-10573
   Abstract »    Full Text »    PDF »
Viral Blip Dynamics during Highly Active Antiretroviral Therapy.
M. Di Mascio, M. Markowitz, M. Louie, C. Hogan, A. Hurley, C. Chung, D. D. Ho, and A. S. Perelson (2003)
J. Virol. 77, 12165-12172
   Abstract »    Full Text »    PDF »
Identification of T cell-signaling pathways that stimulate latent HIV in primary cells.
D. G. Brooks, P. A. Arlen, L. Gao, C. M. R. Kitchen, and J. A. Zack (2003)
PNAS 100, 12955-12960
   Abstract »    Full Text »    PDF »
Rational Design of Drugs That Induce Human Immunodeficiency Virus Replication.
D. H. Hamer, S. Bocklandt, L. McHugh, T.-W. Chun, P. M. Blumberg, D. M. Sigano, and V. E. Marquez (2003)
J. Virol. 77, 10227-10236
   Abstract »    Full Text »    PDF »
Susceptibilities of Simian Immunodeficiency Virus to Protease Inhibitors.
A. C. Giuffre, J. Higgins, R. W. Buckheit Jr., and T. W. North (2003)
Antimicrob. Agents Chemother. 47, 1756-1759
   Abstract »    Full Text »    PDF »
Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.
T.-W. Chun, J. S. Justement, R. A. Lempicki, J. Yang, G. Dennis Jr., C. W. Hallahan, C. Sanford, P. Pandya, S. Liu, M. McLaughlin, et al. (2003)
PNAS 100, 1908-1913
   Abstract »    Full Text »    PDF »
Increased Affinity and Stability of an Anti-HIV-1 Envelope Immunotoxin by Structure-based Mutagenesis.
L. McHugh, S. Hu, B. K. Lee, K. Santora, P. E. Kennedy, E. A. Berger, I. Pastan, and D. H. Hamer (2002)
J. Biol. Chem. 277, 34383-34390
   Abstract »    Full Text »    PDF »
Effects of Prostratin on T-Cell Activation and Human Immunodeficiency Virus Latency.
Y. D. Korin, D. G. Brooks, S. Brown, A. Korotzer, and J. A. Zack (2002)
J. Virol. 76, 8118-8123
   Abstract »    Full Text »    PDF »
Efficient Virus Extinction by Combinations of a Mutagen and Antiviral Inhibitors.
N. Pariente, S. Sierra, P. R. Lowenstein, and E. Domingo (2001)
J. Virol. 75, 9723-9730
   Abstract »    Full Text »    PDF »
Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics.
C. M. Hogan and S. M. Hammer (2001)
Ann Intern Med 134, 978-996
   Abstract »    Full Text »    PDF »
Positive and Negative Aspects of the Human Immunodeficiency Virus Protease: Development of Inhibitors versus Its Role in AIDS Pathogenesis.
K. Ikuta, S. Suzuki, H. Horikoshi, T. Mukai, and R. B. Luftig (2000)
Microbiol. Mol. Biol. Rev. 64, 725-745
   Abstract »    Full Text »    PDF »
Renal Epithelium Is a Previously Unrecognized Site of HIV-1 Infection.
L. A. BRUGGEMAN, M. D. ROSS, N. TANJI, A. CARA, S. DIKMAN, R. E. GORDON, G. C. BURNS, V. D. D'AGATI, J. A. WINSTON, M. E. KLOTMAN, et al. (2000)
J. Am. Soc. Nephrol. 11, 2079-2087
   Abstract »    Full Text »
Mechanisms of HIV-associated lymphocyte apoptosis.
A. D. Badley, A. A. Pilon, A. Landay, and D. H. Lynch (2000)
Blood 96, 2951-2964
   Abstract »    Full Text »    PDF »
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression.
R. T. Davey Jr., N. Bhat, C. Yoder, T.-W. Chun, J. A. Metcalf, R. Dewar, V. Natarajan, R. A. Lempicki, J. W. Adelsberger, K. D. Miller, et al. (1999)
PNAS 96, 15109-15114
   Abstract »    Full Text »    PDF »
Transfer of Human CD4+ T Lymphocytes Producing Beta Interferon in Hu-PBL-SCID Mice Controls Human Immunodeficiency Virus Infection.
V. Vieillard, S. Jouveshomme, N. Leflour, E. Jean-Pierre, P. Debre, E. De Maeyer, and B. Autran (1999)
J. Virol. 73, 10281-10288
   Abstract »    Full Text »
Latent reservoirs of HIV: Obstacles to the eradication of virus.
T.-W. Chun and A. S. Fauci (1999)
PNAS 96, 10958-10961
   Full Text »    PDF »
Replication-Competent Rhabdoviruses with Human Immunodeficiency Virus Type 1 Coats and Green Fluorescent Protein: Entry by a pH-Independent Pathway.
E. Boritz, J. Gerlach, J. E. Johnson, and J. K. Rose (1999)
J. Virol. 73, 6937-6945
   Abstract »    Full Text »
Use of Real-Time PCR and Molecular Beacons To Detect Virus Replication in Human Immunodeficiency Virus Type 1-Infected Individuals on Prolonged Effective Antiretroviral Therapy.
S. R. Lewin, M. Vesanen, L. Kostrikis, A. Hurley, M. Duran, L. Zhang, D. D. Ho, and M. Markowitz (1999)
J. Virol. 73, 6099-6103
   Abstract »    Full Text »
Definition of the Stage of Host Cell Genetic Restriction of Replication of Human Immunodeficiency Virus Type 1 in Monocytes and Monocyte-Derived Macrophages by Using Twins.
H. M. Naif, S. Li, M. Alali, J. Chang, C. Mayne, J. Sullivan, and A. L. Cunningham (1999)
J. Virol. 73, 4866-4881
   Abstract »    Full Text »
The Susceptibility to X4 and R5 Human Immunodeficiency Virus-1 Strains of Dendritic Cells Derived In Vitro From CD34+ Hematopoietic Progenitor Cells Is Primarily Determined by Their Maturation Stage.
B. Canque, Y. Bakri, S. Camus, M. Yagello, A. Benjouad, and J. C. Gluckman (1999)
Blood 93, 3866-3875
   Abstract »    Full Text »    PDF »
Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy.
L. Zhang, B. Ramratnam, K. Tenner-Racz, Y. He, M. Vesanen, S. Lewin, A. Talal, P. Racz, A. S. Perelson, B. T. Korber, et al. (1999)
N. Engl. J. Med. 340, 1605-1613
   Abstract »    Full Text »    PDF »
Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy.
G. S. Ogg, X. Jin, S. Bonhoeffer, P. Moss, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, A. Hurley, et al. (1999)
J. Virol. 73, 797-800
   Abstract »    Full Text »    PDF »
Tat-Associated Kinase, TAK, Activity Is Regulated by Distinct Mechanisms in Peripheral Blood Lymphocytes and Promonocytic Cell Lines.
C. H. Herrmann, R. G. Carroll, P. Wei, K. A. Jones, and A. P. Rice (1998)
J. Virol. 72, 9881-9888
   Abstract »    Full Text »    PDF »
Reconsidering targeted toxins to eliminate HIV infection: You gotta have HAART.
E. A. Berger, B. Moss, and I. Pastan (1998)
PNAS 95, 11511-11513
   Abstract »    Full Text »    PDF »
HIV-1 Tat Interacts with Cyclin T1 to Direct the P-TEFb CTD Kinase Complex to TAR RNA.
M.E. GARBER, P. WEI, and K.A. JONES (1998)
Cold Spring Harb Symp Quant Biol 63, 371-380
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)